US Patent Issued to Merck Sharp & Dohme on Dec. 30 for "Solution formulations of engineered anti-IL-23p19 antibodies" (Michigan, New Jersey Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,509, issued on Dec. 30, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Solution formulations of engineered anti-IL-23p19 antibodies" was invented by Ramesh S. Kashi (Kenilworth, N.J.) and Aniket Badkar (Portage, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides high concentration solution formulations of anti-human interleukin-23 p19 (IL-23p19) antibody hum13B8-b, and their use in treating various disorders."

The patent was filed on Dec. 9, 2013, under Application No. 14/651,946.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...